Statistics
Total Visits
Views | |
---|---|
Combined targeting of JAK2 and Bcl-2/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitors | 135 |
Combined targeting of JAK2 and Bcl-2/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitors | 123 |
Total Visits per Month
November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
---|---|---|---|---|---|---|---|
Combined targeting of JAK2 and Bcl-2/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitors | 7 | 1 | 2 | 0 | 5 | 5 | 0 |
File Downloads
Views | |
---|---|
hdl_103601.pdf(legacy) | 83 |
hdl_103601.pdf | 46 |
Top Country Views
Views | |
---|---|
Germany | 95 |
United States | 83 |
China | 16 |
France | 13 |
Australia | 9 |
Netherlands | 8 |
Vietnam | 8 |
Ireland | 5 |
Argentina | 3 |
Taiwan | 2 |
Top City Views
Views | |
---|---|
Ashburn | 30 |
Fairfield | 14 |
Nürnberg | 9 |
Hanoi | 8 |
Rotterdam | 8 |
Leawood | 7 |
Tettnang Castle | 7 |
Kaleen | 6 |
Dublin | 5 |
Zhengzhou | 5 |